Immunome Stock Price on November 14, 2024
| IMNM Stock | USD 9.82 0.40 4.25% |
If you're considering investing in Immunome Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immunome stands at 9.82, as last reported on the 23rd of November, with the highest price reaching 10.03 and the lowest price hitting 9.32 during the day. Immunome holds Efficiency (Sharpe) Ratio of -0.16, which attests that the entity had a -0.16% return per unit of risk over the last 3 months. Immunome exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunome's Market Risk Adjusted Performance of (0.24), standard deviation of 4.01, and Risk Adjusted Performance of (0.09) to validate the risk estimate we provide.
At this time, Immunome's Stock Based Compensation is very stable compared to the past year. . At this time, Immunome's Price Book Value Ratio is very stable compared to the past year. As of the 23rd of November 2024, Price To Book Ratio is likely to grow to 1.86, while Price Earnings Ratio is likely to drop (2.09). Immunome Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immunome |
Sharpe Ratio = -0.1631
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMNM |
Estimated Market Risk
| 3.94 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.64 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immunome is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunome by adding Immunome to a well-diversified portfolio.
Price Book 2.7359 | Enterprise Value Ebitda (0.72) | Price Sales 60.5127 | Shares Float 44.8 M | Wall Street Target Price 30 |
Immunome Main Headline on 14th of November 2024
Janus Henderson Groups Strategic Acquisition of Immunome Inc... by gurufocus.com
Overview of the Recent Transaction On September 30, 2024, Janus Henderson Group PLC significantly increased its stake in Immunome Inc , a biopharmaceutica
Immunome Valuation on November 14, 2024
It is possible to determine the worth of Immunome on a given historical date. On November 14, 2024 Immunome was worth 11.57 at the beginning of the trading date compared to the closed value of 11.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunome stock. Still, in general, we apply an absolute valuation method to find Immunome's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunome where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunome's related companies.
| Open | High | Low | Close | Volume | |
| 12.74 | 12.77 | 11.55 | 11.59 | 613,682 | |
11/14/2024 | 11.57 | 11.66 | 10.70 | 11.14 | 1,350,565 |
| 11.19 | 11.19 | 9.64 | 9.90 | 3,166,549 |
| Backtest Immunome | | | Immunome History | | | Immunome Valuation | Previous | Next |
Immunome Trading Date Momentum on November 14, 2024
| On November 15 2024 Immunome was traded for 9.90 at the closing time. The top price for the day was 11.19 and the lowest listed price was 9.64 . The trading volume for the day was 3.2 M. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 11.13% . The trading delta at closing time against the current closing price is 15.08% . |
Immunome Fundamentals Correlations and Trends
By evaluating Immunome's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunome's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunome financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunome Stock history
Immunome investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunome is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunome will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunome stock prices may prove useful in developing a viable investing in Immunome
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 19.8 M | 11.7 M | |
| Net Loss | -33.8 M | -32.1 M |
Immunome Quarterly Net Working Capital |
|
Immunome Stock Technical Analysis
Immunome technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunome Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Immunome cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immunome November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunome stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunome shares will generate the highest return on investment. By undertsting and applying Immunome stock market strength indicators, traders can identify Immunome entry and exit signals to maximize returns
Immunome Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunome's price direction in advance. Along with the technical and fundamental analysis of Immunome Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunome to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (1.16) | |||
| Treynor Ratio | (0.25) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunome. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunome. If investors know Immunome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunome listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.94) | Revenue Per Share 0.189 | Quarterly Revenue Growth (0.18) | Return On Assets (0.40) | Return On Equity (2.76) |
The market value of Immunome is measured differently than its book value, which is the value of Immunome that is recorded on the company's balance sheet. Investors also form their own opinion of Immunome's value that differs from its market value or its book value, called intrinsic value, which is Immunome's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunome's market value can be influenced by many factors that don't directly affect Immunome's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunome's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.